ArticleTransboundary and emerging diseases2025
Descriptive Epidemiological Analysis for the First Outbreak of Lumpy Skin Disease in Japan in 2024.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Windborne Dispersal of Arthropod Vectors as a Pathway for Lumpy Skin Disease Virus Introduction into South Korea: A Multi-Species, Source-Attributed Modelling Study.Animals : an open access journal from MDPI · 2026Article
- Development of a Duplex TaqMan-MGB qPCR Assay for Differential Detection of Chinese Epidemic Lumpy Skin Disease Virus Strains and Goatpox Virus.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lumpy skin disease (LSD) is a transboundary emerging disease of cattle and water buffaloes that threatens the livestock industry globally. Japan experienced its first outbreak in November 2024. This study aimed to describe the spatial and temporal characteristics of this outbreak and estimate the transmissibility using a mathematical model for within-farm transmission. The first and second cases were confirmed on dairy farms in Itoshima City, Fukuoka Prefecture, southern Japan, on November 6, 2024. Twenty-two farms were confirmed during this outbreak, with 17 cases in Itoshima City and the other two municipalities in Fukuoka Prefecture. The third case occurred in Kumamoto Prefecture on November 8, 2024, and was linked to the long-distance movement of potentially infected cattle via the livestock market from the first case on October 18, 2024. Two additional cases were detected near the third case. Control measures included isolation and voluntary culling of infected cattle; voluntary movement restrictions on infected, suspected, and apparently healthy cattle on the same premises; and voluntary suspension of the raw milk and semen shipments from infected and suspected animals. These measures were voluntary; however, no violations were reported. Vector control was achieved with insecticides and insect-proof netting. Voluntary vaccination was conducted within a 20 km radius of affected farms in Fukuoka Prefecture. Mathematical modeling of within-farm transmission dynamics revealed a transmission rate of 0.0031 (95% CI: 0.002-0.0044) per day. The basic reproduction number was 3.51 (95% CI: 2.26-4.98) based on a herd size of 49 and an infectious period of 23.1 days. Although the outbreak was geographically limited, this study highlights key epidemiological features of LSD, including its high transmission rate and long-distance transmission via cattle movement. Japan has a persisting LSD virus (LSDV)incursion risk due to recent outbreaks in Asia. Strengthening preparedness, including awareness among farmers and veterinarians, emergency vaccination plans, vector control, traceability, and quarantine protocols for cattle movement, is essential to mitigate future outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.